Discover 1,707 paid clinical trials in Bloomfield Hills, Michigan. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,707
Evaluating Novel Healthcare Approaches to Nurturing and Caring for Hospitalized Elders
Location: Ann Arbor MI, Pittsburgh PA, Madison WI,
Sponsor: University of Michigan
Sex: All
Age: 70+
Code: NCT05929703
Recruiting
Melodi Matrix™ in Breast Reconstruction
for
Breast Reconstruction
Location: Ann Arbor MI, Columbus OH, Pittsburgh PA, Rochester MN,
Sponsor: Melodi Health, Inc.
Sex: Female
Age: 22+
Code: NCT06027996
Recruiting
A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer
for
Advanced or Metastatic Colorectal Cancer
Location: Ann Arbor MI, Toronto, Ottawa, Nashville TN,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT05379595
Phase1, Phase2, Recruiting
Quantitative MRI for Myelofibrosis
for
Myelofibrosis
Location: Ann Arbor MI
Sponsor: University of Michigan Rogel Cancer Center
Sex: All
Age: 18 - 70+
Code: NCT01973881
Recruiting
Efficacy and Safety of CSL222 (Etranacogene Dezaparvovec) Gene Therapy in Adults With Hemophilia B With Pretreatment Adeno-associated Virus Serotype 5 (AAV5) Neutralizing Antibodies (Nabs)
for
Hemophilia B
Location: Ann Arbor MI, Hamilton, Pittsburgh PA, Houston TX,
Sponsor: CSL Behring
Sex: All
Age: 18+
Code: NCT06003387
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Assess the Efficacy and Safety of Efgartigimod PH20 SC in Adults With Systemic Sclerosis
for
Systemic Sclerosis (SSc)
Location: Ann Arbor MI, Chicago IL, Columbia MD, Baltimore MD,
Sponsor: argenx
Sex: All
Age: 18+
Code: NCT06655155
Phase2, Recruiting
American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) Diagnostic and Classification Criteria for Primary Systemic Vasculitis
Location: Ann Arbor MI, Ontario, Cleveland OH, Hamilton, Toronto,
Sponsor: University of Oxford
Sex: All
Age: 18+
Code: NCT01066208
Recruiting
A Phase II Study of Ensifentrine in Non-Cystic Fibrosis Bronchiectasis
for
Non-cystic Fibrosis Bronchiectasis
Location: Ann Arbor MI, Columbus OH, Hammond IN,
Sponsor: Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA
Sex: All
Age: 18 - 70+
Code: NCT06559150
Phase2, Recruiting
Study to Evaluate Biological & Clinical Effects of Significantly Corrected CFTR Function in Infants & Young Children
for
Cystic Fibrosis
Location: Ann Arbor MI, Grand Rapids MI, Columbus OH,
Sponsor: Sonya Heltshe
Sex: All
Age: 0 - 10
Code: NCT04509050
Recruiting
A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
for
Chronic Kidney Disease
Location: Flint MI, Valparaiso IN, Winston-Salem NC, Albany NY,
Sponsor: Novo Nordisk A/S
Sex: All
Age: 18+
Code: NCT06717698
Phase2, Recruiting
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
for
Myelofibrosis
Location: Ann Arbor MI, Columbus OH, Toronto, Chicago IL,
Sponsor: Sumitomo Pharma America, Inc.
Sex: All
Age: 18+
Code: NCT04176198
Phase1, Phase2, Recruiting
A Phase 1 Study of LY5830966 in Participants With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) Who Have Been Failed by a Type I JAK2 Inhibitor (JAK2i)
for
Primary Myelofibrosis
Location: Ann Arbor MI, Columbus OH, Cincinnati OH, St Louis MO,
Sponsor: Ajax Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06343805
Phase1, Recruiting
Multicenter Trial of Antibiotic Eluting Graft for Promoting New Bone Growth in/Near Infected Bone Cavities
for
Periprosthetic Joint Infections
Location: Ann Arbor MI, Columbus OH, Skokie IL, Indianapolis IN,
Sponsor: Elute, Inc.
Sex: All
Age: 22+
Code: NCT05361941
Recruiting
A Proof-of-Concept Study to Learn Whether Linvoseltamab Can Eliminate Abnormal Plasma Cells That May Lead to Multiple Myeloma in Adult Patients With High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma
for
Monoclonal Gammopathy of Undetermined Significance (MGUS),
Location: Ann Arbor MI, Baltimore MD, Philadelphia PA,